- Home
- PAVS vs CTOR Comparison
PAVS vs CTOR Comparison
Compare PAVS & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- CTOR
- Stock Information
- Founded
- PAVS 2004
- CTOR 2021
- Country
- PAVS United States
- CTOR United States
- Employees
- PAVS N/A
- CTOR N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- CTOR
- Sector
- PAVS Health Care
- CTOR
- Exchange
- PAVS Nasdaq
- CTOR NYSE
- Market Cap
- PAVS 89.6M
- CTOR 63.7M
- IPO Year
- PAVS 2019
- CTOR N/A
- Fundamental
- Price
- PAVS $0.98
- CTOR $5.20
- Analyst Decision
- PAVS
- CTOR Buy
- Analyst Count
- PAVS 0
- CTOR 2
- Target Price
- PAVS N/A
- CTOR $6.00
- AVG Volume (30 Days)
- PAVS 4.5K
- CTOR 3.3M
- Earning Date
- PAVS 07-31-2025
- CTOR 08-11-2025
- Dividend Yield
- PAVS N/A
- CTOR N/A
- EPS Growth
- PAVS N/A
- CTOR N/A
- EPS
- PAVS N/A
- CTOR N/A
- Revenue
- PAVS $6,613,273.00
- CTOR N/A
- Revenue This Year
- PAVS N/A
- CTOR N/A
- Revenue Next Year
- PAVS N/A
- CTOR N/A
- P/E Ratio
- PAVS N/A
- CTOR N/A
- Revenue Growth
- PAVS 2.50
- CTOR N/A
- 52 Week Low
- PAVS $0.32
- CTOR $0.55
- 52 Week High
- PAVS $1.50
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- PAVS 46.30
- CTOR N/A
- Support Level
- PAVS $0.83
- CTOR N/A
- Resistance Level
- PAVS $0.98
- CTOR N/A
- Average True Range (ATR)
- PAVS 0.05
- CTOR 0.00
- MACD
- PAVS 0.01
- CTOR 0.00
- Stochastic Oscillator
- PAVS 45.05
- CTOR 0.00
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.